Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone De Leo

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Endocrine|September 5, 2020
Lenvatinib as first-line treatment for advanced thyroid cancer: long progression-free survivalSimone De Leo, Marta Di Stefano, Luca Persani, et al.
Frontiers in Oncology|July 21, 2022
Daily Management of Patients on Multikinase Inhibitors' TreatmentCarla Colombo, Simone De Leo, Matteo Trevisan, et al.
Minerva Pediatrics|January 15, 2024
Vitamin D levels and lipid profile in children and adolescents: a tight correlationDaniele Ceruti, Carla Colombo, Martina Loiodice, et al.
Thyroid : Official Journal of the American Thyroid Association|November 3, 2022
Hypocalcemia During Lenvatinib Treatment for Advanced Thyroid Cancer: Clinical Features and Management in a Real-Life SettingSimone De Leo, Matteo Trevisan, Carla Colombo, et al.
Frontiers in Endocrinology|January 31, 2020
Differentiated Thyroid Cancer, From Active Surveillance to Advanced Therapy: Toward a Personalized MedicineAntonio Matrone, Maria Cristina Campopiano, Alice Nervo, et al.
The Journal of Clinical Endocrinology and Metabolism|November 2, 2018
Primary Adrenal Insufficiency During Lenvatinib or Vandetanib and Improvement of Fatigue After Cortisone Acetate TherapyCarla Colombo, Simone De Leo, Marta Di Stefano, et al.
European Thyroid Journal|April 20, 2024
Impact of systemic treatments for advanced thyroid cancer on the adrenal cortexCarla Colombo, Daniele Ceruti, Massimiliano Succi, et al.
Endocrine|July 20, 2022
Lenvatinib-induced hypocalcaemia due to transient primary hypoparathyroidismMatteo Trevisan, Carla Colombo, Noemi Giancola, et al.
European Thyroid Journal|February 20, 2020
Body Composition and Leptin/Ghrelin Levels during Lenvatinib for Thyroid CancerSimone De Leo, Carla Colombo, Marta Di Stefano, et al.
International Journal of Cancer|June 25, 2015
Fetal cell microchimerism in papillary thyroid cancer: A role in the outcome of the diseaseValentina Cirello, Carla Colombo, Michela Perrino, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Endocrine|September 5, 2020
Lenvatinib as first-line treatment for advanced thyroid cancer: long progression-free survivalSimone De Leo, Marta Di Stefano, Luca Persani, et al.
Frontiers in Oncology|July 21, 2022
Daily Management of Patients on Multikinase Inhibitors' TreatmentCarla Colombo, Simone De Leo, Matteo Trevisan, et al.
Minerva Pediatrics|January 15, 2024
Vitamin D levels and lipid profile in children and adolescents: a tight correlationDaniele Ceruti, Carla Colombo, Martina Loiodice, et al.
Thyroid : Official Journal of the American Thyroid Association|November 3, 2022
Hypocalcemia During Lenvatinib Treatment for Advanced Thyroid Cancer: Clinical Features and Management in a Real-Life SettingSimone De Leo, Matteo Trevisan, Carla Colombo, et al.
Frontiers in Endocrinology|January 31, 2020
Differentiated Thyroid Cancer, From Active Surveillance to Advanced Therapy: Toward a Personalized MedicineAntonio Matrone, Maria Cristina Campopiano, Alice Nervo, et al.
The Journal of Clinical Endocrinology and Metabolism|November 2, 2018
Primary Adrenal Insufficiency During Lenvatinib or Vandetanib and Improvement of Fatigue After Cortisone Acetate TherapyCarla Colombo, Simone De Leo, Marta Di Stefano, et al.
European Thyroid Journal|April 20, 2024
Impact of systemic treatments for advanced thyroid cancer on the adrenal cortexCarla Colombo, Daniele Ceruti, Massimiliano Succi, et al.
Endocrine|July 20, 2022
Lenvatinib-induced hypocalcaemia due to transient primary hypoparathyroidismMatteo Trevisan, Carla Colombo, Noemi Giancola, et al.
European Thyroid Journal|February 20, 2020
Body Composition and Leptin/Ghrelin Levels during Lenvatinib for Thyroid CancerSimone De Leo, Carla Colombo, Marta Di Stefano, et al.
International Journal of Cancer|June 25, 2015
Fetal cell microchimerism in papillary thyroid cancer: A role in the outcome of the diseaseValentina Cirello, Carla Colombo, Michela Perrino, et al.
Pageof 6